![image](https://github.com/user-attachments/assets/8712e406-799f-42ab-89ec-b08f86673fe1)


***Higher survival rate** *9+rs17376848/*rs17376848 
https://www.pharmgkb.org/clinicalAnnotation/1451287440
https://www.pharmgkb.org/variant/PA166153874/variantAnnotation

![image](https://github.com/user-attachments/assets/c0b36b3b-8c72-49a4-bb00-40f0178b70cd)

![image](https://github.com/user-attachments/assets/4c1273b9-b340-41c7-ac04-fe388413bf95)



*1/*4 vs *1+rs10509681/*4

![image](https://github.com/user-attachments/assets/e293193e-510e-4c5a-be85-43bc8f202116)




* 191 patients/2381 (total lung cancer patients) received cancer related drug `filtered_cancer_drugs.csv`
* 24 cancer related drugs in total 
